arrow
R

René Günther

Technische Universität Dresden
H指数:29
被引数:3,259

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Motor phenotypes and neurofilament light chain in genetic amyotrophic lateral sclerosis—results from a multicenter screening program

运动表型与神经丝轻链在遗传性肌萎缩侧索硬化症中的表现——多中心筛查项目的结果

2025-12-120
OA
Compound Muscle Action Potential (CMAP) Amplitude Trajectories and Pattern in Adults with 5q-Spinal Muscular Atrophy Receiving Nusinersen Therapy: A Multicenter, Binational Observational Study

复合肌肉动作电位(CMAP)振幅轨迹和模式:接受nusinersen治疗的5q-脊髓性肌萎缩症成年患者的一项多中心、两国观察性研究

2025-11-010
OAAI
Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen – a multicenter observational study

192例接受nusinersen治疗的脊髓性肌萎缩症(SMA)成年患者的呼吸功能——一项多中心观察性研究

2025-09-290
OA
Phenotypic intrafamilial variability of 5q-associated spinal muscular atrophy: A systematic multicentre sibling study

5q相关脊髓性肌萎缩症的表型家族内变异性:一项系统性多中心同胞研究

2025-09-120
PRE
Activation of polo-like kinase 1 correlates with selective motor neuron vulnerability in familial ALS

Polo-like激酶1的活化与家族性ALS中运动神经元的选择性易损性相关。

2025-08-250
PREAI
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis

靶向蛋白质组学在Tofersen治疗中发现与超氧化物歧化酶1相关的肌萎缩侧索硬化症的新型应答标志物

2025-08-090
OAAI
Self-assessment of amyotrophic lateral sclerosis functional rating scale on the patient's smartphone proves to be non-inferior to clinic data capture

ALS功能评分量表的患者自我评估在智能手机上进行,证明其不劣于临床数据采集。

2025-02-220
OA
Shared prognostic information in amyotrophic lateral sclerosis - systematic assessment of the patients' perception of neurofilament light chain and the ALS functional rating scale

肌萎缩性侧索硬化症的共享预后信息-患者对神经丝轻链的感知和ALS功能评定量表的系统评估

2025-02-060
OAAI
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre study

患者和护理人员对肌萎缩性侧索硬化症的多维和姑息治疗的看法-德国多中心研究的协议

2024-07-041
OAAI
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy
2024-07-031
OAAI
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study
2024-04-019
OA
Effects of tofersen treatment in patients with SOD1-ALS in a real-world setting - a 12-month multicenter cohort study from the German early access program

tofersen治疗对现实环境中SOD1-ALS患者的影响-来自德国早期访问计划的12个月多中心队列研究

2024-03-0118
OAAI